3. Cohen RD, Larson LR, Roth JM, Becker RV, Mummert LL. The cost of hospitalization in Crohn’s disease. Am J Gastroenterol. 2000;95:524–30.PubMedCrossRef 4. Block S. Don’t take it lying down…
Drug Formulation Delivery system Dosage form Release location Azo-bonded formulations Sulfasalazine (Azulfidine®) Azo bond of 5-ASA to sulfapyridine Broken down by colonic bacteria to release active 5-ASA moiety Tablet 500…
Blood or serum Complete blood count Serum albumin Erythrocyte sedimentation rate C-reactive protein Serologies Anti-neutrophil cytoplasmic antibody Anti-Saccharomyces cerevisiae antibody Antibodies to outer membrane porin Antibodies to flagellin NOD2 genetics…
Fig. 11.1 MRCP of a 17-year-old patient with PSC. Note the intrahepatic and extrahepatic beading of the biliary tree with sequential strictures and saccular dilatations. The common bile duct wall…
Fig. 49.1 Timing in Molecular Alterations in Sporadic Colorectal Cancer and Colitis-Associated Colorectal Cancer (From Gastroenterology, 2004) [1] IBD-associated CRCs share several features in common with sporadic CRC. First, they…
Immunization Type Route of administration Patient age at time of recommended administration Hepatitis B Inactivated Parenteral 0–1 year (3 doses) Diphtheria and tetanus toxoids and acellular pertussis Inactivated Parenteral 2–6…
Safe to use when indicated Limited data but appear safe Contraindicated Oral, topical mesalamine Olsalazine Methotrexate Sulfasalazine Azathioprine/6MP Thalidomide Corticosteroids Biologics Diphenoxylate Total parenteral nutrition Cyclosporine Loperamide Metronidazole Ciprofloxacin* …
Major depressive disorder A.At least five of the following symptoms during a 2-week period; at least one of the symptoms is either one or two: 1.Depressed mood most of the…
Short-term Induce clinical remission Maintain clinical remission Improve patient’s quality of life Long-term Heal mucosa Decrease hospitalization/surgery and overall costs Reduce disease-related and therapy-related complications Promote growth and pubertal development…
Fig. 36.1 Diffuse inflammation with loss of vascular pattern and ulceration, typical of the pattern seen in ulcerative colitis He continued to do well and infliximab was stopped after the…
